Sort
78,016 grants matching “breast cancer”
Illinois Oncology Research Association Community Clinical Oncology Program
$998,654John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2009 · CA
Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy
$998,506Daniel Delubac · Xilis, Inc. · R44 · FY2023 · CA
Spatial genomics analysis of tumor samples
$998,481Kirsten Frieda · Spatial Genomics, Inc. · R44 · FY2023 · CA
Spatial genomics analysis of tumor samples
$998,481Kirsten Frieda · Spatial Genomics, Inc. · R44 · FY2024 · CA
Fast Acousto-Optic Tomography System
$998,456Paul Shnitser · Physical Optics Corporation · R44 · FY2010 · CA
Enhancing Primary Care Capacity for Cancer Survivorship Care Delivery in Community Health Clinics
$998,444Bijal A. Balasubramanian · University Of Texas Hlth Sci Ctr Houston · U01 · FY2024 · CA
Howard/Hopkins Cancer Centers Partnership
$998,376William G Nelson · Johns Hopkins University · U54 · FY2007 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$998,324Irving Lerner Weissman · Stanford University · R35 · FY2022 · CA
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema
$998,174Michael Vitoldovich Paukshto · Fibralign Corporation · R44 · FY2018 · CA
COMBINED EXPERIMENTAL AND AI-BASED DEEP LEARNING APPROACH TO LOW DOSE AND DOSE-RATE BREAST CANCER RADIATION RISK PREDICTION
$998,119Board Of Regents Of Nevada System Of Higher Education · · FY2025 · Department of Energy
OTHER FUNCTIONS R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH), UNIVERSAL REAGENT SET
$998,116Solulink Biosciences · N44 · FY2012 · CA
Leadership, Planning and Evaluation
$997,983Alan Ashworth · University Of California, San Francisco · P30 · FY2024 · CA
MOUSE CANCER MODELS VIA TGF-BETA RII LOSS
$997,931Vanderbilt University · U01 · FY2002 · CA
Developing predictive biomarkers in metastatic breast cancer using LiquidBiopsy
$997,908Paul Dempsey · Cynvenio Biosystems, Inc. · N44 · FY2013 · CA
Leadership, Planning and Evaluation
$997,892Alan Ashworth · University Of California, San Francisco · P30 · FY2023 · CA
Automated Systems for Detection and Molecular Characterization of Circulating Tum
$997,818Yuling Luo · Advanced Cell Diagnostics, Inc. · R44 · FY2010 · CA
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema
$997,783Michael Vitoldovich Paukshto · Fibralign Corporation · R44 · FY2017 · CA
A RESOURCE FOR BIOMEDICAL MASS SPECTROMETRY
$997,525Washington University · P41 · FY2003 · RR
THE ROLE OF NF1 IN MAMMARY DEVELOPMENT, BREAST CANCER, AND ENDOCRINE RESISTANCE
$997,500Van Andel Research Institute · · FY2021 · Defense Health Agency
Integrated photoacoustic and fluorescence imaging system for anatomical, functional, and molecular characterization of murine models
$997,451Sergey A Ermilov · Photosound Technologies, Inc. · R44 · FY2022 · OD
Homogeneous Nanoparticle-Based Assays for Protease Detection
$997,365Daniel Sobek · Zymera, Inc. · N44 · FY2012 · CA
Biostatistics and Data Management
$997,353Kathryn L Lunetta · Roswell Park Cancer Institute Corp · P01 · FY2015 · CA
LISTOS for Cancer Control - Leveraging Implementation Science To Optimize Strategies for Cancer Control
$997,335Maria Eulalia Fernandez · University Of Texas Hlth Sci Ctr Houston · U54 · FY2023 · CA
DISCOVERY OF ORALLY BIOAVAILABLE TUBULIN INHIBITORS TO OVERCOME TAXANE RESISTANCE IN METASTATIC BREAST CANCER
$997,190University Of Tennessee · · FY2020 · Defense Health Agency
Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50
$997,176Ellen M Velie · Michigan State University · R01 · FY2013 · CA